This content is machine translated ESMO 2017 in Madrid Blocking the “escape route” for the tumor Upsets in first-line therapy of non-small cell EGFR-mutated lung cancer are imminent. With the FLAURA trial, osimertinib is confidently presenting itself for the first time as a treatment option for…
View Post 6 min This content is machine translated European Lung Cancer Conference 2016 in Geneva Is there a vaccine for malignant mesothelioma coming soon? Once again, the European Lung Cancer Conference was held in Geneva. Once again, the focus was primarily on non-small cell lung cancer. Therapies targeting mutated and non-mutated variants of EGFR…
